Atyr Pharma Is A Clinical Stage Biotechnology Company Based In San Diegocaliforniafounded In 2003The Company Focuses On Developing Innovative Therapeutics For Rare And Challenging Diseasesparticularly Fibrosis And Interstitial Lung Diseasesilds Atyr Leverages Insights From Trna Synthetase Biologyexploring The Regulatory Roles Of These Enzymes In Immune Modulation And Tissue Repair The Company S Lead Candidateefzofitimodatyr1923 Is An Immunomodulatory Protein Targeting Conditions Such As Pulmonary Sarcoidosis And Scleroderma Related Ildatyr Is Also Developing Atyr0101 For Fibrosis And Atyr0750 For Liver Disordersthe Company Collaborates With Academic Institutions To Enhance Its Research Efforts And Aims To Address Unmet Medical Needs In Rare Diseasesunder The Leadership Of Ceo Sanjay Shuklaatyr Is Committed To Patient Centric Drug Development And Advancing Its Proprietary Platform For Next Generation Immunotherapies
